{
  "zip": "103-8668",
  "sector": "Healthcare",
  "fullTimeEmployees": 47495,
  "longBusinessSummary": "Takeda Pharmaceutical Company Limited engages in the research, development, manufacturing, and marketing of pharmaceutical products, over-the-counter medicines and quasi-drug consumer products, and other healthcare products. It offers pharmaceutical products in the areas of gastroenterology; oncology; neuroscience; and rare diseases, such as rare metabolic and hematology, and heredity angioedema, as well as plasma-derived therapies and vaccines. The company provides its products under the ENTYVIO, GATTEX/REVESTIVE, ALOFISEL, NATPARA, ADYNOVATE/ADYNOVI, TAKHZYRO, ELAPRASE, VPRIV, GAMMAGARD LIQUID/KIOVIG, HYQVIA, CUVITRU, ALBUMIN/FLEXBUMIN, NINLARO, and ALUNBRIG brands. It operates in Japan, the United States, Europe and Canada, Russia/CIS, Latin America, rest of Asia, the Middle East, Oceania, and Africa. The company has licensing agreements with TESARO, Inc., Denali Therapeutics, and Wave Life Sciences Ltd; collaboration agreements with Rani Therapeutics LLC, Novimmune S.A., AB Biosciences Inc., Sosei Group Corporation, and LogicBio Therapeutics, Inc.; strategic collaboration with Prometheus Biosciences, Inc; a license and research agreement with The University of Texas MD Anderson Cancer Center; a research collaboration agreements with Enzyre BV and Cerevance; a collaboration agreement with Artisan Bio, Inc.; and a multi-target rare disease collaboration with Evox Therapeutics Ltd., as well as licensing agreement with ProThera Biologics Inc. It also has a corporate strategic research alliance with Egle Therapeutics SAS; a strategic partnership with Neurocrine Biosciences, Inc.; Carmine Therapeutics and HemoShear Therapeutics, LLC. Takeda Pharmaceutical Company Limited was founded in 1781 and is headquartered in Tokyo, Japan.",
  "city": "Tokyo",
  "phone": "81 3 3278 2306",
  "country": "Japan",
  "companyOfficers": [],
  "website": "http://www.takeda.com",
  "maxAge": 1,
  "address1": "1-1, Nihonbashi-Honcho 2-chome",
  "fax": "81 3 3278 2268",
  "industry": "Drug Manufacturersâ€”Specialty & Generic",
  "address2": "Chuo-ku",
  "previousClose": 35.88,
  "regularMarketOpen": 35,
  "twoHundredDayAverage": 35.732662,
  "trailingAnnualDividendYield": 0.04556856,
  "payoutRatio": 5.069,
  "volume24Hr": null,
  "regularMarketDayHigh": 35,
  "navPrice": null,
  "averageDailyVolume10Day": 96225,
  "totalAssets": null,
  "regularMarketPreviousClose": 35.88,
  "fiftyDayAverage": 36.40091,
  "trailingAnnualDividendRate": 1.635,
  "open": 35,
  "averageVolume10days": 96225,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": 1.68,
  "exDividendDate": 1617062400,
  "beta": 1.091419,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 34.435,
  "priceHint": 2,
  "currency": "USD",
  "trailingPE": 21.216883,
  "regularMarketVolume": 5438,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 53317087232,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 29947,
  "priceToSalesTrailing12Months": null,
  "dayLow": 34.435,
  "ask": 0,
  "ytdReturn": null,
  "askSize": 0,
  "volume": 5438,
  "fiftyTwoWeekHigh": 41.34,
  "forwardPE": 16.166666,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": 3.36,
  "fiftyTwoWeekLow": 25.21,
  "bid": 0,
  "tradeable": false,
  "dividendYield": 0.0468,
  "bidSize": 0,
  "dayHigh": 35,
  "exchange": "PNK",
  "shortName": "TAKEDA PHARMACEUTICAL CO LTD",
  "longName": "Takeda Pharmaceutical Company Limited",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": true,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "TKPHF",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_874540",
  "uuid": "74f106a2-6cf7-334c-ae0b-825f6b0d29c7",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": 0.0174,
  "enterpriseToEbitda": null,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": 2.13,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 1563360000,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": 25.101,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1585612800,
  "heldPercentInstitutions": 0.38694,
  "netIncomeToCommon": null,
  "trailingEps": 1.623,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": 1.3718578,
  "heldPercentInsiders": 0.00104,
  "nextFiscalYearEnd": 1648684800,
  "mostRecentQuarter": 1601424000,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": 1563074632,
  "enterpriseValue": 56093212672,
  "threeYearAverageReturn": null,
  "lastSplitDate": null,
  "lastSplitFactor": null,
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": -0.94,
  "dateShortInterest": null,
  "pegRatio": -228644,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 35,
  "logo_url": "https://logo.clearbit.com/takeda.com"
}